Pharmaceutical advertising and clinical nurse specialist practice

Clinical Nurse Specialist

Volumn 20, Issue 1, 2006, Pages 13-15

  O'Malley, Patricia ^a  

^a MIAMI VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; ARTICLE; DRUG INDUSTRY; DRUG THERAPY; ETHICS; HUMAN; NURSE; UNITED STATES;

ADVERTISING; DRUG INDUSTRY; DRUG THERAPY; HUMANS; NURSE CLINICIANS; UNITED STATES;

EID: 33746606520     PISSN: 08876274     EISSN: 15389782     Source Type: Journal    
DOI: 10.1097/00002800-200601000-00005     Document Type: Short Survey

References (16)

1. Sharfstein SS. Big pharma and American psychiatry: the good, bad and the ugly. Psych News. 2005;40(16):3.
2. Wazana A. Physicians and the pharmaceutical industry - is a gift ever just a gift? JAMA. 2000;283(3):373-380.
3. Pinkus RL. From Linda Pinkham to Bob Dole: what the changing face of direct-to-consumer advertising reveals about the professionalism of medicine. Kennedy Inst Ethics J. 2002;12(2):141-158.
4. Carroll RJ, Snyder L, Poon P. Consumer ads: how should you handle the pressure? ACP-ASIM Observer. 2000. American College of Physicians-American Society of Internal Medicine: Ethics and Human Rights Committee: Center for Ethics and Professionalism. Available at: www.acponline.org/ethics/ casestudies/consumerads.htm. Accessed September 20, 2005.
5. Mulligan K. Psychiatrists debate ethics of drug marketing. Psych News. 2003;38(18):8.
6. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct to consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293(16):1995-2002.
7. Morris LA, Brinberg D, Klimberg R, Rivera C. The attitudes of consumers toward direct advertising of prescription drugs. Public Health Rep. 1986;101(1):82-89.
8. Atikins C. Thoughts on pharmaceutical companies and gifts to physicians. Psych News. 2005;40(16):33.
9. Roughhead EE, Harvey KJ, Gilbert AL. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Aust N Z J Med. 1998;28(3):306-310.
10. Mamah D. Residents need training to assess drug company influence. Psych News. 2005;40(1):36.
11. Edmunds M. Confusing ethical guidelines dampen pharmaceutical support. Nurs Pract. 2004;29(8):16.
12. Ashmore R, Carver N. The pharmaceutical industry and mental health nursing. Br J Nursing. 2001;10(21):1396-1402.
13. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118(8):881-884.
14. Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003;169(5):405-412.
15. Rosenthal MB, Berndt ER, Donahue JM, et al. Promotion of prescription drugs to consumers. NEJM. 2002;346(7):498-505.
16. Rothman DJ. Medical professionalism-focusing on the real issues. NEJM. 2000;342(17):86.